EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

Samaneh Tokhanbigli, Mehra Haghi, Kamal Dua, Brian Gregory George Oliver

Cancer Drug Resistance · 10.09.2024

DOI: 10.20517/cdr.2024.55 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Drug Resistance, online erschienen am 10.09.2024. Verfasst von Samaneh Tokhanbigli und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, University of Technology Sydney, Sydney, NSW 2007, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated fibroblasts (CAFs) are the vital constituent of the tumor microenvironment, and in communication with other cells, they contribute to tumor progression and metastasis. Fibroblasts are the proposed origin of CAFs, which are mediated by pro-inflammatory cytokines and the recruitment of immune cells akin to wound healing. Although various studies have identified different subpopulations of CAFs in lung cancer, the heterogeneity of CAFs, particularly in lung cancer, and their potential as a therapeutic target remain largely unknown. Notwithstanding CAFs were previously thought to have predominantly tumor-promoting features, their pro- or anti-tumorigenic properties may depend on various conditions and cell origins. The absence of distinct markers to identify CAF subpopulations presents obstacles to the successful therapeutic targeting and treatment of CAFs in cancer. Human clinical and animal studies targeting CAFs have shown that targeting CAFs exacerbates the disease progression, suggesting that subpopulations of CAFs may exert opposing functions in cancer progression. Therefore, it is essential to pinpoint specific markers capable of characterizing these subpopulations and revealing their mechanisms of function. The cell-specific surface markers of CAFs will serve as an initial step in investigating precise CAF subpopulations and their role in diagnosing and targeting therapy against cancer-promoting CAF subsets in lung cancer.

Schlagwörter

Stichwörter der Autor:innen

Fibroblastsinflammationlung cancertargeted therapytherapeutic markers

Autor:innen und Institutionen

  • School of Life Science, University of Technology Sydney, Sydney, NSW 2007, Australia.
  • Respiratory and Cellular Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia.
  • Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2008, Australia.
  • Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Sydney, NSW 2008, Australia.

Zitieren

APA

Tokhanbigli, S., Haghi, M., Dua, K., & Oliver, B. G. G. (2024). Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer. Cancer Drug Resistance. https://doi.org/10.20517/cdr.2024.55

Vancouver

Tokhanbigli S, Haghi M, Dua K, Oliver BGG. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer. Cancer Drug Resistance. 2024. doi:10.20517/cdr.2024.55

BibTeX
@article{Tokhanbigli2024,
  author = {Tokhanbigli, Samaneh and Haghi, Mehra and Dua, Kamal and Oliver, Brian Gregory George},
  title = {Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer},
  journal = {Cancer Drug Resistance},
  year = {2024},
  doi = {10.20517/cdr.2024.55}
}
Kostenlos starten →